UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000044390 |
|---|---|
| Receipt number | R000048719 |
| Scientific Title | Impact of cancer cachexia progression on CYP3A4 and OATP1B activity: Quantitative analysis using endogenous biomarker |
| Date of disclosure of the study information | 2021/06/01 |
| Last modified on | 2025/12/04 09:02:48 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2021/06/01 13:27:34 | ||
| 2 | Update | 2021/06/01 15:14:25 | Date of disclosure of the study information |
|
| 3 | Update | 2021/06/01 15:17:41 | Condition Narrative objectives1 Primary outcomes Key secondary outcomes |
|
| 4 | Update | 2021/06/01 17:20:54 | Narrative objectives1 |
|
| 5 | Update | 2021/12/01 09:24:03 | Key secondary outcomes Key secondary outcomes |
|
| 6 | Update | 2022/06/13 09:52:19 | Recruitment status |
|
| 7 | Update | 2022/12/02 09:07:50 | Date analysis concluded |
|
| 8 | Update | 2023/07/06 08:57:58 | Date analysis concluded |
|
| 9 | Update | 2023/12/07 08:35:15 | Study type Key inclusion criteria |
|
| 10 | Update | 2024/06/03 09:38:57 | Number of participants that the trial has enrolled |
|
| 11 | Update | 2024/10/15 10:39:43 | Public title Acronym Scientific Title Scientific Title:Acronym |
|
| 12 | Update | 2025/06/04 09:45:33 | URL releasing protocol Publication of results URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 13 | Update | 2025/06/04 09:50:15 | Organization Organization Organization Category of Funding Organization |
|
| 14 | Update | 2025/12/04 09:02:48 | Results |
